美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=LIBRIUM
符合检索条件的记录共7
1 页 当前第 1 页  返回检索页
1药品名称LIBRIUM
申请号012249产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格10MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS INTERNATIONAL
2药品名称LIBRIUM
申请号012249产品号002
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格5MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS INTERNATIONAL
3药品名称LIBRIUM
申请号012249产品号003
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格25MG
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS INTERNATIONAL
4药品名称LIBRIUM
申请号012301产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格100MG/AMP
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS NORTH AMERICA LLC
5药品名称LIBRIUM
申请号085461产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态处方药
剂型或给药途径CAPSULE;ORAL规格5MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS INTERNATIONAL
6药品名称LIBRIUM
申请号085472产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态处方药
剂型或给药途径CAPSULE;ORAL规格10MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS INTERNATIONAL
7药品名称LIBRIUM
申请号085475产品号001
活性成分CHLORDIAZEPOXIDE HYDROCHLORIDE市场状态处方药
剂型或给药途径CAPSULE;ORAL规格25MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构VALEANT PHARMACEUTICALS INTERNATIONAL